Mobile

A Multicentre, Randomised, Double-Blind, Parallel Group, 24 Week Study to Compare the Effect of the Salmeterol/Fluticasone Propionate Combination Product (SERETIDE) 50/250mcg with Salmeterol 50mcg Bot...

Mise à jour : Il y a 4 ans
Référence : EUCTR2004-000007-18

A Multicentre, Randomised, Double-Blind, Parallel Group, 24 Week Study to Compare the Effect of the Salmeterol/Fluticasone Propionate Combination Product (SERETIDE) 50/250mcg with Salmeterol 50mcg Both Delivered Twice Daily via the DISKUS/ACCUHALER Inhaler on Lung Function and Dyspnoea in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To compare the effectiveness of SERETIDE 50/250mcg with salmeterol 50mcg both delivered twice daily via the DISKUS/ACCUHALER inhaler on lung function (Trough FEV1) and relief of dyspnoea as measured by the Transition Dyspnoea Index (TDI) in subjects with COPD over a 24 week treatment period.

Critère d'inclusion

  • Study is to be conducted in patients with COPD whose airflow limitation, in terms of percentage of predicted FEV1 is between 50-80% normal

Liens